Related Experiment Video

Updated: Mar 29, 2026

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
07:59

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

1.8K

Treatment Algorithms Based on Tumor Molecular Profiling: The Essence of Precision Medicine Trials

Christophe Le Tourneau1, Maud Kamal1, Apostolia-Maria Tsimberidou1

  • 1Affiliations of authors:Department of Medical Oncology, Institut Curie , Paris & Saint-Cloud , France (CLT, MK, MA); EA7285 Versailles-St-Quentin-en-Yvelines University , France (CLT, RR); Investigational Cancer Therapeutics, M. D. Anderson Cancer Center , Houston, TX (AMT); Drug Development Program, Department of Medical Oncology and Hematology, Princess Margaret Hospital , Toronto , Canada (PB); Department of Genetics, Institut Curie , Paris , France (GP, CC, ER, IB); Department of Pathology, Institut Curie , Paris , France (AVS); Institut Curie / INSERM U900 , Paris , France (NS, XP); Department of Surgery, Institut Curie , Paris & Saint-Cloud , France (RR); Institut Curie, INSERM U830 , Paris , France (OD); EA7331, University of Paris-Descartes , Paris , France (IB).

Journal of the National Cancer Institute
|November 25, 2015
PubMed

Insights

Precision medicine trials use molecular profiling to guide cancer therapy. This study outlines criteria for developing standardized treatment algorithms to ensure reproducible and effective precision medicine approaches.

Area of Science:

  • Oncology
  • Genomics
  • Clinical Trials

Background:

  • High-throughput molecular technologies enable precision medicine (PM) studies, including molecular screening and clinical trials.
  • Molecular profiling identifies tumor alterations to guide targeted therapy selection.
  • Prospective PM trials assess the clinical utility of molecular profiling and compare targeted vs. unselected treatments.

Purpose of the Study:

  • To evaluate the clinical utility of tumor molecular profiling in precision medicine.
  • To determine if targeted therapies based on molecular alterations improve patient outcomes.
  • To establish criteria for developing standardized treatment algorithms in PM trials.

Main Methods:

  • Utilizing treatment algorithms with fixed rules for patient assignment to targeted therapies based on tumor molecular alterations.
  • Summarizing key molecular, biological, and technical criteria for algorithm development.
  • Focusing on standardization and reproducibility in precision medicine clinical trials.

Main Results:

  • Treatment algorithms are crucial for assigning patients to targeted therapies in PM trials.
  • Standardization and reproducibility are essential for reliable algorithm governance.
  • Key molecular, biological, and technical criteria must be addressed for effective algorithm design.

Conclusions:

  • Standardized treatment algorithms are vital for the success of precision medicine clinical trials.
  • Defining clear criteria ensures the consistent and reproducible application of molecular profiling in guiding cancer therapy.
  • This work provides a framework for developing robust treatment algorithms in precision medicine research.

More Related Videos

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

8.1K
Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies13:24

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies

Published on: April 11, 2016

12.4K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.1K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

1.8K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.3K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.2K